Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being
ConditionChronic Pulmonary Aspergillosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorImperial College London
About this trial
To develop and validate a novel disease-specific questionnaire for measuring HRQoL in patients with Chronic Pulmonary Aspergillosis (CPA-HAQ) for use in clinical research, including clinical trials.
Eligibility criteria
Qualifiers
All patients >/= 18 years old and able to provide informed consent
Patients with a diagnosis of chronic pulmonary aspergillosis
To speak and understand English
Able to provide informed consent
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Imperial College London
Lead sponsor
Manchester University NHS Foundation Trust
Collaborator
Tayside Medical Science Centre
Collaborator
Source ClinicalTrials.gov